{"rows":[{"id":2304,"title":"Management of Treatment-Resistant Depression: Challenges and Strategies.","authors":"Voineskos D, Daskalakis ZJ, Blumberger DM","journal":"Neuropsychiatric disease and treatment","publication_date":"2020-01-01","publication_year":2020,"doi":"10.2147/ndt.s198774","pubmed_id":"32021216","openalex_id":"https://openalex.org/W3000386776","source_url":"https://pubmed.ncbi.nlm.nih.gov/32021216/","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Mechanism of Action,Aging,Review Article,Treatment-Resistant Depression","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:24","bibtex":null,"source_record_id":"PMID:32021216","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/32021216/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:32021216","source_url":"https://pubmed.ncbi.nlm.nih.gov/32021216/","doi":"10.2147/ndt.s198774","pmid":"32021216","publication_date":"2020-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1506,"title":"Use of Selective Alternative Therapies for Treatment of OCD.","authors":"Khan I, Jaura TA, Tukruna A, Arif A, Tebha SS, Nasir S, Mukherjee D, Masroor N, Yosufi A","journal":"Neuropsychiatric disease and treatment","publication_date":"2023-01-01","publication_year":2023,"doi":"10.2147/ndt.s403997","pubmed_id":"37041856","openalex_id":"https://openalex.org/W4362614112","source_url":"https://pubmed.ncbi.nlm.nih.gov/37041856/","substance_tags":"psilocybin","topic_tags":"OCD,Mechanism of Action,Clinical Trial,Systematic Review,Review Article,Observational Study,Safety,Adverse Events","study_type":"Systematic Review","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:16","bibtex":null,"source_record_id":"PMID:37041856","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/37041856/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:37041856","source_url":"https://pubmed.ncbi.nlm.nih.gov/37041856/","doi":"10.2147/ndt.s403997","pmid":"37041856","publication_date":"2023-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1359,"title":"Predicting the Intensity of Psychedelic-Induced Mystical and Challenging Experience in a Healthy Population: An Exploratory Post-Hoc Analysis.","authors":"Ko K, Carter B, Cleare AJ, Rucker JJ","journal":"Neuropsychiatric disease and treatment","publication_date":"2023-01-01","publication_year":2023,"doi":"10.2147/ndt.s426193","pubmed_id":"37818448","openalex_id":"https://openalex.org/W4387389328","source_url":"https://pubmed.ncbi.nlm.nih.gov/37818448/","substance_tags":"psilocybin","topic_tags":"Depression,Personality Change,Mystical Experience,Clinical Trial,Healthy Volunteers","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:12","bibtex":null,"source_record_id":"PMID:37818448","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/37818448/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:37818448","source_url":"https://pubmed.ncbi.nlm.nih.gov/37818448/","doi":"10.2147/ndt.s426193","pmid":"37818448","publication_date":"2023-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1252,"title":"Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions.","authors":"Modlin NL, Creed M, Sarang M, Maggio C, Rucker JJ, Williamson V","journal":"Neuropsychiatric disease and treatment","publication_date":"2024-01-01","publication_year":2024,"doi":"10.2147/ndt.s432537","pubmed_id":"38268571","openalex_id":"https://openalex.org/W4391053730","source_url":"https://pubmed.ncbi.nlm.nih.gov/38268571/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Review Article,Safety","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:10","bibtex":null,"source_record_id":"PMID:38268571","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/38268571/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:38268571","source_url":"https://pubmed.ncbi.nlm.nih.gov/38268571/","doi":"10.2147/ndt.s432537","pmid":"38268571","publication_date":"2024-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":847,"title":"Mushrooms, Microdosing, and Mental Illness: The Effect of Psilocybin on Neurotransmitters, Neuroinflammation, and Neuroplasticity.","authors":"Kinderlehrer DA","journal":"Neuropsychiatric disease and treatment","publication_date":"2025-01-01","publication_year":2025,"doi":"10.2147/ndt.s500337","pubmed_id":"39897712","openalex_id":"https://openalex.org/W4406930915","source_url":"https://pubmed.ncbi.nlm.nih.gov/39897712/","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Anxiety,End-of-Life Distress,Neuroplasticity,Receptor Pharmacology,Default Mode Network,Microdosing,Inflammation","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:03","bibtex":null,"source_record_id":"PMID:39897712","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39897712/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39897712","source_url":"https://pubmed.ncbi.nlm.nih.gov/39897712/","doi":"10.2147/ndt.s500337","pmid":"39897712","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}}],"total":5,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Neuropsychiatric disease and treatment","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}